R Targhetta Selected Research

Type 3 von Willebrand Disease

11/2002

Clinical efficacy of highly purified, doubly virus-inactivated factor VIII/von Willebrand factor concentrate (Fanhdi) in the treatment of von Willebrand disease: a retrospective clinical study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Targhetta Research Topics

Disease

2	Hemorrhage 01/2010 - 11/2002
2	von Willebrand Diseases (von Willebrand's Disease) 01/2010 - 11/2002
1	Hemarthrosis 12/2008
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2008
1	Hemophilia A (Haemophilia) 12/2008
1	Type 3 von Willebrand Disease 11/2002
1	Afibrinogenemia (Fibrinogen Deficiency) 12/2001

Drug/Important Bio-Agent (IBA)

2	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2010 - 11/2002
2	von Willebrand FactorIBA 01/2010 - 11/2002
2	Factor VIII (Coagulation Factor VIII)IBA 12/2008 - 11/2002
1	AntibodiesIBA 12/2008
1	Blood Coagulation Factors (Coagulation Factor)IBA 12/2008
1	CoagulantsIBA 11/2002
1	Pharmaceutical PreparationsIBA 11/2002
1	von Willebrand factor drug combination factor VIIIIBA 11/2002
1	Nonsense Codon (Nonsense Mutation)IBA 12/2001
1	Fibrinogen (Factor I)FDA Link 12/2001

Therapy/Procedure

2	Operative Surgical Procedures 01/2010 - 11/2002
1	Minor Surgical Procedures (Minor Surgery) 11/2002
1	Therapeutics 11/2002